Seeing Is Believing

Currently out of the existing stock ratings of Mohit Bansal, 208 are a BUY (63.8%), 117 are a HOLD (35.89%), 1 are a SELL (0.31%).
Analyst Mohit Bansal, currently employed at WELLS FARGO, carries an average stock price target met ratio of 64.32% that have a potential upside of 30.08% achieved within 263 days.
Mohit Bansal’s has documented 649 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on MRK, Merck mpany at 04-Sep-2026.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 11/18/2019. The price target of $115 was fulfilled within 1 day with a profit of $19 (19.79%) receiving and performance score of 197.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Jan-2024
$37
$5.19 (16.32%)
$39
Buy Since 31-Mar-2026
$50
$18.19 (57.18%)
$46
21 days ago
(21-Sep-2026)
3/5 (60%)
$16.05 (47.28%)
72
Hold Since 01-Dec-2022
$34
$2.19 (6.88%)
$31
2 months 5 days ago
(07-Aug-2026)
11/12 (91.67%)
$1.73 (5.36%)
113
Buy Since 05-Mar-2026
$52
$20.19 (63.47%)
$46
2 months 11 days ago
(31-Jul-2026)
1/3 (33.33%)
$21.98 (73.22%)
215
Buy Since 24-Feb-2025
$55
$23.19 (72.90%)
$52
2 months 12 days ago
(30-Jul-2026)
0/11 (0%)
$22.25 (67.94%)
Which stock is Mohit Bansal most bullish on?
Which stock is Mohit Bansal most reserved on?
What Year was the first public recommendation made by Mohit Bansal?